利安隆(300596) - 2019 Q1 - 季度财报

Financial Performance - Total revenue for Q1 2019 reached ¥409,492,579.11, an increase of 26.64% compared to ¥323,360,251.97 in the same period last year[8] - Net profit attributable to shareholders was ¥53,155,962.23, representing a growth of 49.78% from ¥35,488,367.06 year-on-year[8] - Net profit excluding non-recurring gains and losses was ¥43,700,860.22, up 27.74% from ¥34,210,845.47 in the previous year[8] - Basic earnings per share increased to ¥0.2953, a rise of 49.75% compared to ¥0.1972 in the same period last year[8] - The company's net profit for Q1 2019 was not explicitly stated, but the increase in retained earnings was noted at ¥393,577,199.84, compared to ¥362,058,680.49 in the previous year[56] - The net profit attributable to the parent company was CNY 560,358,185.41, compared to CNY 507,202,223.18 in the previous year, representing an increase of about 10.47%[49] - The total comprehensive income for Q1 2019 was CNY 52,943,448.25, compared to CNY 34,639,698.25 in Q1 2018, marking a significant increase of 52.9%[63] - The net profit for Q1 2019 reached CNY 54,024,888.65, representing a growth of 49.6% from CNY 36,115,277.56 in Q1 2018[63] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,125,370,665.37, reflecting a 5.35% increase from ¥2,017,390,322.69 at the end of the previous year[8] - Total current assets as of March 31, 2019, amounted to CNY 1,215,655,861.77, an increase from CNY 1,172,595,824.55 at the end of 2018, reflecting a growth of approximately 3.66%[43] - Total liabilities increased to CNY 973,365,361.61 from CNY 918,219,511.91, reflecting a rise of about 6.00%[47] - The company's total assets reached CNY 2,125,370,665.37, up from CNY 2,017,390,322.69, marking an increase of approximately 5.36%[49] - Total liabilities were reported at ¥777,757,914.36, a slight increase from ¥772,097,825.78 at the end of 2018[54] Cash Flow - The net cash flow from operating activities was -¥18,727,896.77, an improvement of 54.30% compared to -¥40,978,383.50 in the same period last year[8] - Operating cash inflow for the current period was CNY 390,670,693.99, compared to CNY 201,841,412.42 in the previous period, representing an increase of approximately 93.4%[76] - The net cash flow from operating activities was CNY 12,130,007.43, a significant improvement from a net outflow of CNY 30,221,366.45 in the previous period[76] - Cash inflow from financing activities totaled CNY 81,682,901.80, slightly up from CNY 81,660,454.95 in the previous period[78] - The net cash flow from financing activities was CNY 9,798,711.80, down from CNY 50,924,865.76 in the previous period, indicating a decrease of approximately 80.8%[78] - Total cash outflow from investing activities was CNY 105,070,141.37, compared to CNY 55,819,509.68 in the previous period, reflecting an increase of approximately 88.1%[76] Expenses - Total operating costs for Q1 2019 were ¥359,086,016.62, up 27.38% from ¥281,859,061.48 in Q1 2018[57] - Management expenses increased by 59.75% to CNY 19,049,302.54, primarily due to higher employee compensation costs[20] - Financial expenses rose by 76.98% to CNY 8,750,483.96, mainly due to currency fluctuations and increased interest expenses from loans[20] - The company incurred a total tax expense of CNY 9,037,593.86 in Q1 2019, which is an increase from CNY 6,982,466.24 in Q1 2018, reflecting higher profitability[63] Investments and Projects - The company plans to acquire 100% equity of Hengshui Kaiya Chemical Co., Ltd. through a share issuance, which was approved at the shareholders' meeting[25] - The project for expanding the annual production of 11,500 tons of antioxidants has been adjusted to the first phase of the project for producing 125,000 tons of polymer material aging-resistant agents[34] - The aging-resistant agents project is currently under construction, with 17.52% of the investment completed[31] - The company has invested CNY 3,738.95 million in the current quarter, with a cumulative investment of CNY 12,466.15 million[31] Shareholder Information - The company reported a total of 6,692 common shareholders at the end of the reporting period[11] - The company has not faced any overdue commitments from actual controllers, shareholders, or related parties during the reporting period[29] - The company has not implemented any share repurchase during the reporting period[28] Research and Development - Research and development expenses increased to CNY 11,445,299.72, up 20.6% from CNY 9,493,903.93 in the previous year, reflecting the company's commitment to innovation[64] - The new R&D center project has been completed and is in use since the end of 2018[34]